Related references
Note: Only part of the references are listed.Inhibitor of apoptosis proteins in hematological malignancies
S. Fulda
LEUKEMIA (2009)
Quantitative PCR and HER2 testing in breast cancer
Massimo Barberis et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Disturbed XIAP and XAF1 Expression Balance Is an Independent Prognostic Factor in Gastric Adenocarcinomas
Tomotaka Shibata et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
Ying-Hong Shi et al.
HEPATOLOGY (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Immunotherapy of HCC
Tim F. Greten et al.
REVIEWS ON RECENT CLINICAL TRIALS (2008)
Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma
Chao-Ping Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
The inhibitor of apoptosis proteins as therapeutic targets in cancer
Domagoj Vucic et al.
CLINICAL CANCER RESEARCH (2007)
The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours
Carsten Kempkensteffen et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2007)
Overexpression of apollon, an antiapoptotic protein, is associated with poor prognosis in childhood De novo acute myeloid leukemia
Ki Woong Sung et al.
CLINICAL CANCER RESEARCH (2007)
Distribution of neuronal apoptosis inhibitory protein in human tissues
Johannes K. X. Maier et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma
G-Y Chau et al.
HISTOPATHOLOGY (2007)
Livin/ML-IAP as a new target for cancer treatment
Bin Liu et al.
CANCER LETTERS (2007)
Expression parameters of the inhibitors of apoptosis c1AP1 and c1AP2 in renal cell carcinomas and their prognostic relevance
Carsten Kempkensteffen et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas
Tomotaka Shibata et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Brendan P. Eckelman et al.
EMBO REPORTS (2006)
Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma
Rong-Ping Guo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Chromosome alignment and segregation regulated by ubiquitination of survivin
QP Vong et al.
SCIENCE (2005)
Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)
X Ling et al.
LUNG CANCER (2005)
In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma
H Takashima et al.
LIVER INTERNATIONAL (2005)
Motoneuron resistance to apoptotic cell death in vivo correlates with the ratio between X-linked inhibitor of apoptosis proteins (XIAPs) and its inhibitor, XIAP-associated factor 1
D Perrelet et al.
JOURNAL OF NEUROSCIENCE (2004)
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
T Dohi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas
Y Yan et al.
BRITISH JOURNAL OF CANCER (2004)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Identification of XAF1 as an antagonist of XIAP anti-caspase activity
P Liston et al.
NATURE CELL BIOLOGY (2001)
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
DS O'Connor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
